Sensing cell stress and transformation through Vγ9Vδ2 T cell-mediated recognition of the isoprenoid pathway metabolites

被引:74
|
作者
Bonneville, M
Fournié, JJ
机构
[1] CHU Purpan, INSERM, U563, F-31024 Toulouse, France
[2] INSERM, Inst Biol, U601, F-44035 Nantes, France
关键词
immunology; T lymphocytes; gamma/delta T cell receptor; isoprenoid biosynthesis;
D O I
10.1016/j.micinf.2005.03.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
V gamma V delta 2 cells, a major peripheral blood gamma delta T cell subset in adults, recognize non-peptidic phosphorylated metabolites referred to as phosphoantigens (phosphoAg), which are produced by a broad array of prokaryotic and eukaryotic organisms. We will review here the biosynthetic pathways leading to production of phosphoAg and our current understanding of the mode of activation of V gamma 9V delta 2 cells by these compounds. We will also discuss the physiological relevance of this immune recognition process and show how it can enable discrimination by V gamma 9V delta 2 lymphocytes of infected and/or transformed cells. (c) 2005 Elsevier SAS. All rights reserved.
引用
收藏
页码:503 / 509
页数:7
相关论文
共 50 条
  • [41] TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancer
    Beatson, Richard E.
    Parente-Pereira, Ana C.
    Halim, Leena
    Cozzetto, Domenico
    Hull, Caroline
    Whilding, Lynsey M.
    Martinez, Olivier
    Taylor, Chelsea A.
    Obajdin, Jana
    Hoang, Kim Ngan Luu
    Draper, Benjamin
    Iqbal, Ayesha
    Hardiman, Tom
    Zabinski, Tomasz
    Man, Francis
    de Rosales, Rafael T. M.
    Xie, Jinger
    Aswad, Fred
    Achkova, Daniela
    Joseph, Chung-Yang Ricardo
    Ciprut, Sara
    Adami, Antonella
    Roider, Helge G.
    Hess-Stumpp, Holger
    Gyorffy, Balazs
    Quist, Jelmar
    Grigoriadis, Anita
    Sommer, Anette
    Tutt, Andrew N. J.
    Davies, David M.
    Maher, John
    CELL REPORTS MEDICINE, 2021, 2 (12)
  • [42] Chemotherapy and zoledronate sensitize solid tumour cells to Vγ9Vδ2 T cell cytotoxicity
    Stephen R. Mattarollo
    Tony Kenna
    Mie Nieda
    Andrew J. Nicol
    Cancer Immunology, Immunotherapy, 2007, 56 : 1285 - 1297
  • [43] Chemotherapy and zoledronate sensitize solid tumour cells to Vγ9Vδ2 T cell cytotoxicity
    Mattarollo, Stephen R.
    Kenna, Tony
    Nieda, Mie
    Nicol, Andrew J.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (08) : 1285 - 1297
  • [44] A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation
    Yang, Yunyun
    Li, Liping
    Yuan, Linjie
    Zhou, Xiaoying
    Duan, Jianxin
    Xiao, Hongying
    Cai, Ningning
    Han, Shuai
    Ma, Xianqiang
    Liu, Weidong
    Chen, Chun-Chi
    Wang, Lingle
    Li, Xin
    Chen, Jiahuan
    Kang, Ning
    Chen, Jing
    Shen, Zhixun
    Malwal, Satish R.
    Liu, Wanli
    Shi, Yan
    Oldfield, Eric
    Guo, Rey-Ting
    Zhang, Yonghui
    IMMUNITY, 2019, 50 (04) : 1043 - +
  • [45] Leveraging Vγ9Vδ2 T cells against prostate cancer through a VHH-based PSMA-Vδ2 bispecific T cell engager
    King, Lisa A.
    Veth, Myrthe
    Iglesias-Guimarais, Victoria
    Blijdorp, Iris
    Kloosterman, Jan
    Vis, Andre N.
    Roovers, Rob C.
    Hulsik, David Lutje
    Riedl, Thilo
    Adang, Anton E. P.
    Parren, Paul W. H. I.
    van Helden, Pauline M.
    de Gruijl, Tanja D.
    van der Vliet, Hans J.
    ISCIENCE, 2024, 27 (12)
  • [46] Chitosan Nanoparticles Strengthen Vγ9Vδ2 T-Cell Cytotoxicity Through Upregulation Of Killing Molecules And Cytoskeleton Polarization
    Lin, Li
    He, Junyi
    Li, Jiawei
    Xu, Yan
    Li, Jingxia
    Wu, Yangzhe
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 14 : 9325 - 9336
  • [47] IL-21-mediated expansion of Vγ9Vδ2 T cells is limited by the Tim-3 pathway
    Wu, Kangni
    Zhao, Haijun
    Xiu, Yanghui
    Li, Zhifeng
    Zhao, Jintao
    Xie, Shiting
    Zeng, Hanyan
    Zhang, Haiping
    Yu, Lian
    Xu, Bing
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 69 : 136 - 142
  • [48] 5-Azacytidine and Venetoclax Combination Boost Vγ9Vδ2 T Cell Effector Functions
    Le Floch, Anne-Charlotte
    Wieduwild, Elisabeth
    Chretien, Anne-Sophie
    Orlanducci, Florence
    Garulli, Celine
    Bourass, Sarah
    Imbert, Caroline
    De Gassart, Aude
    Vey, Norbert
    Madakamutil, Loui
    Olive, Daniel
    BLOOD, 2022, 140 : 11535 - 11536
  • [49] Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside
    Castella, Barbara
    Vitale, Candida
    Coscia, Marta
    Massaia, Massimo
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2011, 68 (14) : 2419 - 2432
  • [50] Development of V γ 9V δ 2T cell based chemo-immunotherapy in bladder cancer
    Shimizu, Teruki
    Tomogane, Mako
    Miyashita, Masatsugu
    Sano, Yusuke
    Shimizu, Daiki
    Ukimura, Osamu
    Ashihara, Eishi
    CANCER SCIENCE, 2018, 109 : 433 - 433